Synthesis, antiviral and antiproliferative activity of a new class of 5-(alkyl or arylthio)-6-vinyl uracils. 1996

P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla

Uracil derivatives bearing substituted or unsubstituted vinyl groups at position C6 and alkyl- or arylthio groups at position C5 were synthesized and tested in vitro for antiviral and antiproliferative activity. None of the compounds were active against HIV-1. However, some of them inhibited the proliferation of leukemia, lymphoma and solid tumor-derived cell lines at micromolar concentrations. The maximum potency of antiproliferative activity correlates with the presence of unsubstituted vinyl groups and alkyl- or arylthio substituents.

UI MeSH Term Description Entries
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013873 Thionucleotides Nucleotides in which the base moiety is substituted with one or more sulfur atoms.
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.
D014753 Vinyl Compounds Compounds containing the vinyl (-C Compounds, Vinyl
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
July 1997, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
June 2011, Molecules (Basel, Switzerland),
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
January 2002, Farmaco (Societa chimica italiana : 1989),
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
February 2005, Bioorganic & medicinal chemistry letters,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
May 1986, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
September 2003, Bioorganic & medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
November 2001, Journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
June 2020, Archiv der Pharmazie,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
May 2005, European journal of medicinal chemistry,
P G Baraldi, and B Cacciari, and R Romagnoli, and G Spalluto, and L Garuti, and M Roberti, and A Pani, and G Perra, and F Scintu, and N Pinna, and C Musiu, and P La Colla
February 1997, Journal of medicinal chemistry,
Copied contents to your clipboard!